Clinical Trial Update: A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Radspherin in patients with primary advanced epithelial cancer and peritoneal metastasis who are homologous recombination prof…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Radspherin

Snippet

Sponsor: Oncoinvent Solutions AS | Conditions: Peritoneal Carcinomatosis, Ovarian Cancer | Phase 2 | Status: RECRUITING